Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

BACKGROUND: The dynamic change in C-reactive protein (CRP) levels, CRP kinetics, is a prognostic factor for metastatic renal cell carcinoma (mRCC) in the tyrosine kinase inhibitor era. We investigated the impact of early CRP kinetics on the efficacy of nivolumab in patients with mRCC. METHODS: We pe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Fukuda, Shohei, Saito, Kazutaka, Yasuda, Yosuke, Kijima, Toshiki, Yoshida, Soichiro, Yokoyama, Minato, Ishioka, Junichiro, Matsuoka, Yoh, Kageyama, Yukio, Fujii, Yasuhisa
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2021
Teme:
Immunotherapy Biomarkers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7896625/
https://ncbi.nlm.nih.gov/pubmed/33602695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001564
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki